Status:

RECRUITING

Human Laboratory Study of the Effects of Nicotine Product Claims on Appeal, Perceptions, and Use Behavior

Lead Sponsor:

Ohio State University Comprehensive Cancer Center

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Behavior, Risk

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

This study evaluates knowledge, feelings and thoughts regarding nicotine products among young adults who are susceptible to but do not use tobacco/nicotine and adults who use tobacco/nicotine.

Detailed Description

PRIMARY OBJECTIVES: I. Examine the effects of nicotine concentration and source claims on engagement with ONP packaging using laboratory-based psychophysiological assessment. II. Examine the effects...

Eligibility Criteria

Inclusion

  • Young adult susceptible non-users aged 18-24 who have never used ONPs and have never used but are susceptible to using either:
  • combustible tobacco only (cigarettes, cigars, waterpipe)
  • non-combustible tobacco only (ST, ECs, heated tobacco products)
  • or both combustible and non-combustible tobacco (i.e., dual susceptibility)
  • Adult tobacco users aged 18-65 who have never used ONPs OR have used ONPs \>3 months ago and 10 times or less in their lifetime. All adult tobacco users must also be:
  • exclusive combustible tobacco users
  • exclusive non-combustible tobacco users
  • dual users
  • For adult tobacco users, we will define current use as use of combustible and/or non-combustible tobacco every day or some days for 6 months or longer
  • Willing and able to complete an in-person lab visit.

Exclusion

  • Age \< 18 or \> 65
  • Are not susceptible non-users or current tobacco users
  • Are unwilling or unable to complete and in person lab visit.
  • Have used ONPs within the past 3 months
  • Have used ONPs more than 10 times in their lifetime

Key Trial Info

Start Date :

March 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 14 2028

Estimated Enrollment :

450 Patients enrolled

Trial Details

Trial ID

NCT06192316

Start Date

March 1 2024

End Date

September 14 2028

Last Update

February 3 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, United States, 43210